PURA Launches EVERx CBD Sports Water Marketing Campaign In Europe Next Week

PURA Launches EVERx CBD Sports Water Marketing Campaign In Europe Next Week

 

DALLAS, TX -- September 11, 2019 -- InvestorsHub NewsWire -- Puration, Inc. (PURA) today announced the launch of its EVERx CBD Sports Water marketing campaign in Europe.  The campaign will kick off at Arnold Schwarzenegger’s Arnold Sports Festival Europe in Barcelona September 20-22, 2019.  EVERx CBD Sports Water is available already in Europe through select distributors.  With the EVERx CBD Sports Water campaign starting next week, PURA plans to expand its European sales.  Look for more news from the event next week, and in the weeks to follow, look for more news as the EVERx CBD Sports Water marketing campaign in Europe continues to grow.
 

EVERx was officially launched for the first time ever at the Arnold Classic in Columbus, Ohio in 2017.  EVERx now participates at the Arnold Sports Festival events worldwide.  EVERx today is the leading CBD infused sports nutrition beverage with over $1 million in sales in 2018 and over $1 million in sales in the first six months of 2019 and targeting $4 million in sales by 2019 year end.  EVERx is now an official sponsor of Jan Tana’s Body Painting Revolution featured globally at Arnold Sports Festival venues worldwide.

EVERx CBD Sports Water is available for purchase on line at www.USMJ.com hosted by PURA’s partner North American Cannabis Holdings, Inc. (USOTC: USMJ).

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Contact:
Puration, Inc.
Brian Shibley,
[e-mail]
[phone]